DigestRedComo funciona
Red
/
Empresas
Zy
No verificado

Zymeworks Inc.

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasMedicina Salud BienestarVenta al público/Minorista

43 Comunicados de prensa

Ver todos los comunicados de prensa
21/04/2026
Biotecnología
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
17/04/2026
Biotecnología
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
09/04/2026
Biotecnología
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
01/04/2026
Biotecnología
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotecnología
Anuncios breves
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
18/03/2026
Biotecnología
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
17/03/2026
Biotecnología
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
02/03/2026
Biotecnología
Finanzas
Medicina Salud Bienestar
Gestión empresarial/Administración de Empresas
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
27/01/2026
Biotecnología
Zymeworks Announces Participation in Upcoming Investor Conferences
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0
12/01/2026
Biotecnología
Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Fuente
Zymeworks Inc.
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0